Associated Papers
Plasminogen activator inhibitor-1 genotype 4G/5G associates with skin involvement in Armenian familial Mediterranean fever patients.
Kriegshäuser G et al.
Rheumatology International, 2024
Family-based analysis of -675 4G/5G polymorphism in the PAI-1 gene of polycystic ovary syndrome in Chinese population.
Song X et al.
Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology, 2022
Morphometric and Nanomechanical Features of Platelets from Women with Early Pregnancy Loss Provide New Evidence of the Impact of Inherited Thrombophilia.
Andreeva T et al.
International Journal of Molecular Sciences, 2021
Association between the 4G/5G polymorphism of plasminogen activator inhibitor-1 (PAI-1) gene and sudden sensorineural hearing loss in Caucasian population: a meta-analysis.
Wei Z et al.
European Archives of Oto-rhino-laryngology : Official Journal of the European Federation of Oto-rhino-laryngological Societies (eufos) : Affiliated With the German Society for Oto-rhino-laryngology - Head and Neck Surgery, 2021
Clinical and Genetic Heterogeneity in a Large Family with Pseudoxanthoma Elasticum: MTHFR and SERPINE1 Variants as Possible Disease Modifiers in Developing Ischemic Stroke.
Bruno G et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association, 2021
Plasminogen activator inhibitor-1: a potential etiological role in livedoid vasculopathy.
Gao Y et al.
International Wound Journal, 2020
Recurrent Thrombosis: A Case of Hereditary Thromboembolism.
Giofrè MC et al.
The American Journal of Case Reports, 2017
Correlation between factor VII and PAI-1 genetic variants and recurrent miscarriage.
Barlik M et al.
Ginekologia Polska, 2016
MIGRAINE, CAROTID STIFFNESS AND GENETIC POLYMORPHISM.
Kes VB et al.
Acta Clinica Croatica, 2015
Pharmacogenetic considerations for acute lymphoblastic leukemia therapies.
Dulucq S et al.
Expert Opinion on Drug Metabolism & Toxicology, 2014
Plasminogen activator inhibitor 1 and methylenetetrahydrofolate reductase gene mutations in iranian women with polycystic ovary syndrome.
Idali F et al.
American Journal of Reproductive Immunology (new York, N.y. : 1989), 2012
[Genetic variants of endothelial nitric synthase in gestational hypertension and preeclampsia].
Perlik M et al.
Ginekologia Polska, 2012
[Right atrial thrombus: a rare presentation of plasminogen activator inhibitor deficiency].
Cordeiro Piçarra B et al.
Revista Portuguesa De Cardiologia : Orgao Oficial Da Sociedade Portuguesa De Cardiologia = Portuguese Journal of Cardiology : an Official Journal of the Portuguese Society of Cardiology, 2012
[Analysis association of acute ischemic stroke and DNA markers in Russian and Moldavian populations].
Bondarenko EA et al.
Genetika, 2011
[Genetic variability of endothelin-1 system in gestational hypertension and preeclampsia].
Seremak-Mrozikiewicz A et al.
Ginekologia Polska, 2011
Genes and abdominal aortic aneurysm.
Hinterseher I et al.
Annals of Vascular Surgery, 2011
Polymorphisms of plasminogen activator inhibitor-1, angiotensin converting enzyme and coagulation factor XIII genes in patients with recurrent spontaneous abortion.
Aarabi M et al.
The Journal of Maternal-fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 2011
[Polymorphism in the genes of Toll-like receptors type 2 and type 4 (TLR-2 and TLR-4) and the risk of premature rupture of the membranes--preliminary study].
Łukaszewski T et al.
Ginekologia Polska, 2009
Pharmacogenetics in cardiovascular antithrombotic therapy.
Marín F et al.
Journal of the American College of Cardiology, 2009
[The connection between Arg353Gln polymorphism of coagulation factor VII and recurrent miscarriages].
Seremak-Mrozikiewicz A et al.
Ginekologia Polska, 2009
Prevalence of prothrombotic polymorphisms in Greece.
Gialeraki A et al.
Genetic Testing, 2008
Inherited thrombophilias in pregnant patients: detection and treatment paradigm.
Lockwood CJ
Obstetrics and Gynecology, 2002
The 4G/5G polymorphism of the plasminogen activator inhibitor-1 gene is associated with severe preeclampsia.
Yamada N et al.
Journal of Human Genetics, 2000
The relationship of mutations in the MTHFR, prothrombin, and PAI-1 genes to plasma levels of homocysteine, prothrombin, and PAI-1 in children and adults.
Balasa VV et al.
Thrombosis and Haemostasis, 1999
ABO blood group, hypercoagulability, and cardiovascular and cancer risk.
Franchini M et al.
Critical Reviews in Clinical Laboratory Sciences, 0
The procoagulant status. Hypercoagulability as a risk factor of primary and secondary infertility.
Neamţu SD et al.
Romanian Journal of Morphology and Embryology = Revue Roumaine De Morphologie Et Embryologie, 0